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Glyphosate is one of the most common active ingredients in plant protection products used 
to prevent unwanted plant growth in plant cultivation and to accelerate the maturation 
process of crops (desiccation). Glyphosate inhibits a plant enzyme which is essential for the 
biosynthesis of certain amino acids. This enzyme is not found in animals or humans. 
The approval procedure for glyphosate as an active ingredient is currently being revised at 
the European level. Germany is hereby the Rapporteur Member State (RMS). For the 
purpose of reassessing the health implications of this active substance, the Federal Institute 
for Risk Assessment (BfR) has, in its capacity as the competent federal institute, examined 
and evaluated more than 150 new and original toxicological studies conducted in accordance 
with the OECD guidelines and Good Laboratory Practice (GLP) and over 900 new studies 
published in scientific journals, which included the analysis of numerous documents not 
previously considered. This investigation did not provide any indications that glyphosate has 
carcinogenic, reprotoxic or teratogenic effects on test animals, nor did the documents give 
any cause for substantially changing the health-based limit values. The first draft of the 
Renewal Assessment Report (RAR) was issued at the end of 2013 and subsequently 
submitted to the European Food Safety Authority (EFSA) by the Federal Office of Consumer 
Protection and Food Safety (BVL). Adopting a peer review system, public consultation with 
experts and stakeholders was completed under the guidance of EFSA in 2014. 
 
Changes and extensions to the report on the assessment of the health implications of 
glyphosate by the BfR following public consultation 
Taking into account the submitted comments of the member states, the EFSA, the 
Glyphosate Task Force (GTF) and the public consultation, the Renewal Assessment Report 
(RAR) was revised. Moreover, all GTF documents additionally requested by the BfR, as well 
as articles not yet considered, or newly published in scientific journals were all incorporated. 
This revised version of the RAR was sent to the BVL in December 2014.  
For the revised version, a total of about 350 comments and references were individually 
checked, assessed and, when required, taken into account in the revision of the RAR. 
The revised version incorporated a significantly increased number of biographical references, 
and included more and longer sections on the detection of glyphosate in human urine. It also 
contained more information on its effects on agricultural production animals. However, the 
amendments also covered the areas of carcinogenicity and mutagenicity. Even though a 
higher absorption rate through the skin is now assumed for the representative formula, i.e. a 
plant protection product containing glyphosate as its active ingredient, this has not changed 
the basic assessment of the substance. 
Further activities of the Federal Institute for Risk Assessment (BfR) 
As the BfR communicated to the EFSA as early as July 2014, the evaluation of the public 
consultation led to the conclusion that some questions require general clarification at the 
European level, since they are of major importance and from the viewpoint of substance 
effects are not directly connected to glyphosate. 
The BfR therefore recommended to the European Commission to hold a general discussion 
with experts specialising in health-based risk assessment from the member states, 
universities, the industry, NGOs and politicians, in order to consult with them on these points 
and to adumbrate possible solutions for an improved assessment of the health risks posed 
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by plant protection products. As part of these solutions, possible new toxicological 
assessment procedures and reinforced integration of alternative method validation must be 
taken into account and ways must be found to better characterise active ingredient / co-
formulant combinations. 
The BfR continues, within the framework of separate projects, to investigate certain aspects 
of health assessment. A publication on the detection of glyphosate in human urine has 
already been completed [1]. A further publication on the effects of a glyphosate-containing 
herbicide on the bacteria population in an artificial rumen model and on parameters of the 
rumen metabolism are currently underway, as is a comparative study of poisoning incidents 
in Germany and in a Brazilian federal state. 
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